platelet-rich fibrin
Biologicalautologous platelet-rich fibrin was isolated from venous blood of each patient by defined centrifugation methods
NCT Number: NCT02397122
The aim of the trial is to evaluate the effectiveness of coronally advanced flap (CAF)+connective tissue graft(CTG)+platelet-rich fibrin(PRF) combination in Miller I and II recession treatment by comparing with CAF+CTG. 40 patients were surgically treated either with CAF+CTG+PRF (test group) or CAF+CTG (control group). Clinical parameters of plaque index (PI), gingival index (GI), vertical recession (VR), probing depth (PD), attachment level (AL), keratinized tissue width (KTW), horizontal recession (HR), MGJ localization (L-MGJ), tissue thickness (TT) were recorded at baseline, 3 months (PS1) and 6 months (PS2) post-surgery. Root coverage (RC), complete RC (CRC), attachment gain (AG), and keratinized tissue change (KTC) were also calculated.
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
Given the encouraging effects of platelet-rich fibrin (PRF) in healing and regeneration, it has been hypothesized that PRF might develop the outcomes obtained with coronally advanced flap (CAF)+connective tissue graft(CTG). Therefore, it was aimed to evaluate the effectiveness of CAF + CTG + PRF in Miller Class I and II recession defect treatment by comparing the outcomes with CAF + CTG in a preliminary, controlled, randomized clinical trial (RCT) with a 6-month follow-up. The study was conducted with 40 patients randomly grouped in half shares into indicated study groups. After phase I therapy, clinical variables including plaque index (PI), gingival index (GI), vertical recession (VR), probing depth (PD), attachment level (AL), keratinized tissue width (KTW), horizontal recession (HR), MGJ localization (L-MGJ), tissue thickness (TT) were recorded. The surgical sites were prepared by using sulcular and adjacent vertical incisions and CTGs were harvested from the palatal regions. Different from CAF+CTG group, PRF was prepared by obtaining 10 ml venous blood, centrifugation and extraction of the gel containing highly concentrated platelet cells in CAF+CTG+PRF patients. Then the gel was placed over the exposed root surface in the same group. The CAF was primarily closed and postoperative instructions were given. After suture removal at second postoperative week, the patients were followed-up by monthly recall visits. Same periodontal clinical variables were recorded 3 and 6 months after surgery.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
autologous platelet-rich fibrin was isolated from venous blood of each patient by defined centrifugation methods
connective tissue graft was harvested from the palatal region of each patient by single incision method
buccal gingival flap was raised by sharp-blunt-sharp dissection and positioned coronally to cover connective tissue graft (and platelet-rich fibrin gel)
Time frame: Baseline, 6 weeks and 6 months
Measured from cementoenamel junction to margin of the gingiva by periodontal probe
Time frame: Baseline, 6 weeks and 6 months
measured horizontally between two borders of the recession at the line tangential to cementoenamel junction by periodontal probe
Time frame: Baseline, 6 weeks and 6 months
measured from margin of the gingiva to gingival sulcus base by periodontal probe
Time frame: Baseline, 6 weeks and 6 months
measured from cementoenamel junction to gingival sulcus base by periodontal probe
Time frame: Baseline, 6 weeks and 6 months
measured from margin of the gingiva to mucogingival junction by periodontal probe
Time frame: Baseline, 6 weeks and 6 months
under local anesthesia, measured from 1.5 mm below the margin of the gingiva with a spreader and its stopper silicon disc. Then, distance of the marked point was measured by using a standardized caliper to the closest 0.1 mm by periodontal probe
Kırıkkale University
Other
The Adjunctive Effect of Platelet Rich Fibrin to Connective Tissue Graft in the Treatment of Buccal Recession Defects. Results of a Randomized Parallel Group Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07736833
Gingival Diseases, Gingival Recession
Tanta, Gharbia Governorate, Egypt
View Trial DetailsNCT05470660
Gingival Diseases, Gingival Recession
Cairo, Egypt
View Trial DetailsNCT07291583
Gingival Diseases, Gingival Recession
Ankara, None Selected, Turkey (Türkiye)
View Trial DetailsNCT07616960
Gingival Diseases, Gingival Recession
Taipei, Taiwan
View Trial Details